{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:11:50Z","timestamp":1769109110169,"version":"3.49.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1097\/mat.0b013e31828579af","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T15:42:33Z","timestamp":1361634153000},"page":"130-135","source":"Crossref","is-referenced-by-count":17,"title":["Ischemic Versus Nonischemic Dilated Cardiomyopathy"],"prefix":"10.1097","volume":"59","author":[{"given":"Athanasios","family":"Tsiouris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamil","family":"Borgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hassan W.","family":"Nemeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaetano","family":"Paone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R2-6-20210129","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"R4-6-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): Randomised controlled trial.","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"R5-6-20210129","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/oxfordjournals.eurheartj.a060321","article-title":"Relative efficacy of angiotensin converting enzyme inhibitors on mortality of patients with congestive heart failure: implications of randomized trials and role of the aetiology (ischaemic or non-ischaemic) of heart failure.","volume":"13","author":"Nony","year":"1992","journal-title":"Eur Heart J"},{"key":"R6-6-20210129","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/0002-9149(90)91166-4","article-title":"Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20 secondary to ischemic or nonischemic dilated cardiomyopathy.","volume":"66","author":"Stevenson","year":"1990","journal-title":"Am J Cardiol"},{"key":"R7-6-20210129","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0002-9149(87)91183-0","article-title":"Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy.","volume":"59","author":"Likoff","year":"1987","journal-title":"Am J Cardiol"},{"key":"R8-6-20210129","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2007.07.014","article-title":"Differences in management and outcome of ischemic and non-ischemic cardiomyopathy.","volume":"129","author":"Ng","year":"2008","journal-title":"Int J Cardiol"},{"key":"R9-6-20210129","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0735-1097(98)00400-8","article-title":"Etiology and response to drug treatment in heart failure.","volume":"32","author":"Follath","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"R10-6-20210129","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0167-5273(97)00163-0","article-title":"Ischemic versus idiopathic cardiomyopathy: Differing neurohumoral profiles despite comparable peak oxygen uptake.","volume":"61","author":"Deng","year":"1997","journal-title":"Int J Cardiol"},{"key":"R11-6-20210129","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0735-1097(03)00043-3","article-title":"Differential gene expression and genomic patient stratification following left ventricular assist device support.","volume":"41","author":"Blaxall","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"R12-6-20210129","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0003-4975(01)03621-9","article-title":"Disease-specific remodeling of cardiac mitochondria after a left ventricular assist device.","volume":"73","author":"Heerdt","year":"2002","journal-title":"Ann Thorac Surg"},{"key":"R13-6-20210129","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/labinvest.3700670","article-title":"Type IV collagen degradation in the myocardial basement membrane after unloading of the failing heart by a left ventricular assist device.","volume":"87","author":"Bruggink","year":"2007","journal-title":"Lab Invest"},{"key":"R15-6-20210129","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1161\/01.CIR.102.22.2713","article-title":"Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.","volume":"102","author":"Heerdt","year":"2000","journal-title":"Circulation"},{"key":"R16-6-20210129","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.healun.2006.05.011","article-title":"Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern.","volume":"25","author":"Bruggink","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"R17-6-20210129","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases.","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur Heart J"},{"key":"R18-6-20210129","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0735-1097(97)00235-0","article-title":"Clinical determinants of mortality in patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy.","volume":"30","author":"Bart","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R19-6-20210129","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10741-012-9300-8","article-title":"The paradox of left ventricular assist device unloading and myocardial recovery in end-stage dilated cardiomyopathy: Implications for heart failure in the elderly.","volume":"17","author":"Butler","year":"2012","journal-title":"Heart Fail Rev"},{"key":"R20-6-20210129","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.healun.2010.11.011","article-title":"Proteomic profiling of the human failing heart after left ventricular assist device support.","volume":"30","author":"de Weger","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R22-6-20210129","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0735-1097(02)01713-8","article-title":"Left ventricular assist device in end-stage heart failure: Persistence of structural myocyte damage after unloading. An immunohistochemical analysis of the contractile myofilaments.","volume":"39","author":"de Jonge","year":"2002","journal-title":"J Am Coll Cardiol"}],"container-title":["ASAIO Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAT.0b013e31828579af","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:20:21Z","timestamp":1620958821000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002480-201303000-00006"}},"subtitle":["The Implications of Heart Failure Etiology on Left Ventricular Assist Device Outcomes"],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mat.0b013e31828579af","relation":{},"ISSN":["1058-2916"],"issn-type":[{"value":"1058-2916","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}